Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02787681 · ClinicalTrials.gov registry record · NA

Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube

A NA study, sponsored by Loma Linda University.

Completed
Registry status
NA
Development phase
71
Enrollment target

NCT02787681: Completed NA study, sponsored by Loma Linda University.

NCT02787681 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 71 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02787681, a NA study, has completed, sponsored by Loma Linda University.

COMPLETED
Registry status
NA
Development phase
71 participants
Enrollment target

Study Summary

The aim of this study is to verify the safety and accuracy of an FDA-approved device called the NEMO™ Gauge to aide in the proper positioning of the endotracheal tube (ETT), inserted in the lungs of patients admitted to the intensive care unit. The hope is that the NEMO™ Gauge is able to properly determine the correct position of the endotracheal tube without the use of a chest radiograph (chest x-ray). The study investigators anticipate sixty-eight (68) subjects will participate in this study at three (3) study centers in the Inland Empire of Southern California, with subjects being enrolled at Loma Linda University Medical Center, Riverside University Medical Center and Loma Linda Veterans Affairs Hospital.

Primary Outcome

The number of patients with correct Endotracheal tube position

Interventions

  • DEVICE NEMO Gauge

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2016-08-15
Est. Completion 2017-07-14
Phase NA
Loma Linda University

237 total trials

What the finished NCT02787681 record still lists

NCT02787681 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which NEMO Gauge is the first listed.

NCT02787681 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02787681 about?

NCT02787681 is a clinical study titled "Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube". The aim of this study is to verify the safety and accuracy of an FDA-approved device called the NEMO™ Gauge to aide in the proper positioning of the endotracheal tube (ETT), inserted in the lungs of patients admitted to the intensive care unit. The hope is that the NEMO™ Gauge is able to properly de...

What is the current status of trial NCT02787681?

This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2016-08-15. Estimated completion is 2017-07-14.

What interventions are being tested in trial NCT02787681?

The interventions under investigation include: NEMO Gauge (DEVICE).

Who is sponsoring clinical trial NCT02787681?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02787681's enrollment target sits among peer trials

71 1102nd of 2000 higher than 898 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05452889 · 71 participants · Early Phase 1

    PET Image in PAH Patients

  • NCT05766943 · 71 participants · NA

    Reduction of Myopotential Interference With Smart Pass in S-ICD Patients

  • NCT06229678 · 71 participants · Early Phase 1

    Ketones, SGLT2, HFrEF

  • NCT06377566 · 71 participants · Phase 2

    A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02787681, the US trial registry maintained by the National Library of Medicine. NCT02787681 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.